Cancer Gene Therapy Market – By Type (Ex-vivo, In-vivo), Therapy (Oncolytic Virotherapy, Gene-induced Immunotherapy, Gene Transfer), Product (Viral Vectors {Adenoviruses, Lentiviruses}, Non-viral Vectors), End-use, Global Forecast (2024 – 2032)
Report ID: GMI763
Selected License: | $4,850 |
Discount: | $728 |
Call us or write to us: